CDK2-IN-9

CDK2-IN-9 is a potent and selective CDK2 inhibitor (IC50 = 0.63 μM) with demonstrated anti-proliferative activity in melanoma research. It induces cell cycle arrest in S and G2/M phases and promotes apoptosis in vitro, highlighting its potential as a tool for investigating cell cycle dysregulation in cancer models.